ARQT Operating Cash Flow
Arcutis Biotherapeutics Inc · Operating Cash Flow
ARQT Operating Cash Flow
Latest reported$39.31Mperiod ending
ARQT TTM Operating Cash Flow (-$14.09M → $39.31M)
TTM operating cash flow
High-resolution chart · PNG
ARQT operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 39,309,000 | |
| 26,994,000 | |
| -5,625,000 | |
| -32,558,000 | |
| -65,492,000 | |
| -110,935,000 | |
| -112,158,000 | |
| -167,654,000 | |
| -176,950,000 | |
| -198,316,000 | |
| -247,057,000 | |
| -261,878,000 | |
| -285,589,000 | |
| -281,084,000 | |
| -257,715,000 | |
| -238,359,000 | |
| -211,548,000 | |
| -185,399,000 | |
| -174,627,000 | |
| -155,489,000 | |
| -148,767,000 | |
| -138,697,000 | |
| -113,504,000 | |
| -97,730,000 | |
| -74,290,000 | |
| -56,772,000 | |
| -42,836,000 | |
| -31,877,000 | |
| -23,962,000 | |
| -18,439,000 | |
| -14,085,000 |